Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents

被引:60
作者
Conway, Jerry O. [1 ]
Sherwood, Laura J. [1 ]
Collazo, M. Thelma [1 ]
Garza, John A. [1 ]
Hayhurst, Andrew [1 ]
机构
[1] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
MONOCLONAL-ANTIBODY; IMMUNOLOGICAL CHARACTERIZATION; IMMUNE-RESPONSE; BINDING DOMAIN; A NEUROTOXIN; TOXIN; FRAGMENTS; CHAIN; SEQUENCE; COMPLEX;
D O I
10.1371/journal.pone.0008818
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper the development of highly specific immunoassays, especially if based on polyclonal antisera. Here we employ facile recombinant antibody technology to subtractively select ligands to each of the 7 BoNT serotypes, resulting in populations with very high specificity for their intended serotype. Methods and Findings: A single llama was immunized with a cocktail of 7 BoNT toxoids to generate a phage display library of single domain antibodies (sdAb, VHH or nanobodies) which were selected on live toxins. Resulting sdAb were capable of detecting both toxin and toxin complex with the best combinations able to detect 100s-10s of pg per 50 mu L sample in a liquid bead array. The most sensitive sdAb were combined in a heptaplex assay to identify each of the BoNT serotypes in buffer and milk and to a lesser extent in carrot juice, orange juice and cola. Several anti-A(1) sdAb recognized A2 complex, showing that subtype cross-reactivity within a serotype was evident. Many of our sdAb could act as both captor and tracer for several toxin and toxin complexes suggesting sdAb can be used as architectural probes to indicate BoNT oligomerisation. Six of 14 anti-A clones exhibited inhibition of SNAP-25 cleavage in the neuro-2A assay indicating some sdAb had toxin neutralizing capabilities. Many sdAb were also shown to be refoldable after exposure to high temperatures in contrast to polyclonal antisera, as monitored by circular dichroism. Conclusions: Our panel of molecularly flexible antibodies should not only serve as a good starting point for ruggedizing assays and inhibitors, but enable the intricate architectures of BoNT toxins and complexes to be probed more extensively.
引用
收藏
页数:12
相关论文
共 86 条
[1]
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain [J].
Adekar, Sharad P. ;
Takahashi, Tsuyoshi ;
Jones, R. Mark ;
Al-Saleem, Fetweh H. ;
Ancharski, Denise M. ;
Root, Michael J. ;
Kapadnis, B. P. ;
Simpson, Lance L. ;
Dessain, Scott K. .
PLOS ONE, 2008, 3 (08)
[2]
Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries [J].
Amersdorfer, P ;
Wong, C ;
Smith, T ;
Chen, S ;
Deshpande, S ;
Sheridan, R ;
Marks, JD .
VACCINE, 2002, 20 (11-12) :1640-1648
[3]
Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[4]
Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices [J].
Bagramyan, Karine ;
Barash, Jason R. ;
Arnon, Stephen S. ;
Kalkum, Markus .
PLOS ONE, 2008, 3 (04)
[5]
Subunit vaccine against the seven serotypes of botulism [J].
Baldwin, Michael R. ;
Tepp, William H. ;
Przedpelski, Amanda ;
Pier, Christina L. ;
Bradshaw, Marite ;
Johnson, Eric A. ;
Barbieri, Joseph T. .
INFECTION AND IMMUNITY, 2008, 76 (03) :1314-1318
[6]
Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E [J].
Baldwin, MR ;
Tepp, WH ;
Pier, CL ;
Bradshaw, M ;
Ho, MF ;
Wilson, BA ;
Fritz, RB ;
Johnson, EA ;
Barbieri, JT .
INFECTION AND IMMUNITY, 2005, 73 (10) :6998-7005
[7]
Cell entry strategy of clostridial neurotoxins [J].
Binz, Thomas ;
Rummel, Andreas .
JOURNAL OF NEUROCHEMISTRY, 2009, 109 (06) :1584-1595
[8]
Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum [J].
Carter, Andrew T. ;
Paul, Catherine J. ;
Mason, David R. ;
Twine, Susan M. ;
Alston, Mark J. ;
Logan, Susan M. ;
Austin, John W. ;
Peck, Michael W. .
BMC GENOMICS, 2009, 10
[9]
Chames Patrick, 2002, Methods Mol Biol, V178, P147
[10]
Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species [J].
Chen, F ;
Kuziemko, GM ;
Stevens, RC .
INFECTION AND IMMUNITY, 1998, 66 (06) :2420-2425